🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 100% of ingredients have research evidence
A Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Capsule(s) Serving Size
60 Servings
Botanical Product Type
100% Evidence Coverage

Supplement Facts — Evidence Check

6 mg
📊 Market median: 470.0mg (230 products) 📚 9 studies (Tier A: 3, B: 3)
This product: 6mg

Other Ingredients

Rice, Powder Gelatin Water, Purified

Label Claims — Verification

All Other
Structure/Function
All Other (100% of products) Structure/Function (81% of products) Nutrient (3% of products)

Target Groups

Adult (18 - 50 Years)

Product Information

📋 Directions for Use

Recommendations: Take one (1) capsule daily, or as directed by your longevity physician.

⚠️ Warnings & Precautions

Tamper evident. Do not use if seal is broken.

Keep out of reach of children.

Consult your physician if you are pregnant or breastfeeding before using this product.

🧪 Formulation Notes

Longevity's Immune Factor A contains Astragaloside IV, a major active constituent in the roots of the Chinese herb Astragalus.

Astragaloside IV supports age-related changes in the immune system. It has also been shown to help maintain a healthy inflammatory response and to support healthy aging of the brain, nerves, heart, and blood vessels.

Additional Information

Store in a cool dry place.

Order: 866-86-YOUNG, LMClinic.com

Product Details

DSLD Entry Date 2024-03-22
Product Type Botanical
Form Capsule
DSLD ID 308014
Data Updated 2026-04-11

Research Evidence

9 Research Sources
60 Avg Quality Score
5 Meta Analysis
2 Cochrane Review
1 Systematic Review
1 Rct
B Astragalus (a traditional Chinese medicine) for treating chronic kidney disease.
Cochrane Review The Cochrane database of systematic reviews
B Oral Astragalus (Huang qi) for preventing frequent episodes of acute respiratory tract infection in children.
Cochrane Review The Cochrane database of systematic reviews
B Evaluating traditional Chinese medicine (TCM) Jie Geng and Huang Qi combination on reducing surgical site infections in colorectal cancer surgeries: A systematic review and meta-analysis
Meta Analysis International wound journal 2024
B Chronic fatigue syndrome post-COVID-19: triple-blind randomised clinical trial of Astragalus root extract
Rct BMJ supportive & palliative care 2025
B Efficacy and potential pharmacological mechanism of Astragalus-Salvia miltiorrhiza combination in diabetic nephropathy: integrating meta-analysis, network pharmacology, molecular docking, and experimental validation
Meta Analysis Renal failure 2025
B Renal protective effects and mechanisms of Astragalus membranaceus for diabetic kidney disease in animal models: An updated systematic review and meta-analysis
Meta Analysis Phytomedicine : international journal of phytotherapy and phytopharmacology 2024
C Adjuvant therapy with Astragalus membranaceus for post-stroke fatigue: a systematic review
Systematic Review Metabolic brain disease 2020
C Efficacy of Astragalus Membranaceus (Huang Qi) for Cancer-Related Fatigue: A Systematic Review and Meta-Analysis of Randomized Controlled Studies
Meta Analysis Integrative cancer therapies 2025
C The Effect of Astragalus on Humoral and Cellular Immune Response: A Systematic Review and Meta-Analysis of Human Studies
Meta Analysis Complementary medicine research 2023
View all evidence for Astragalus →

Compare Similar Products

View all Astragalus products →